Neurocrine Biosciences to Present at Two Upcoming Conferences on September 16 and September 22

News provided by

Sep 09, 2010, 02:00 ET

SAN DIEGO, Sept. 9 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Stifel Nicolaus 2010 Healthcare Conference in Boston and at the UBS Global Life Sciences Conference in New York City.

The live presentation for the Stifel Nicolaus conference takes place on Thursday, September 16, 2010 at 10:20 a.m. Eastern Time / 7:20 a.m. Pacific Time.

The live presentation for the UBS conference takes place on Wednesday, September 22, 2010 at 1:00 p.m. Eastern Time / 10:00 a.m. Pacific Time.

Both presentations will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software. A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, irritable bowel syndrome, insomnia and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

SOURCE Neurocrine Biosciences, Inc.